-
Murray, ML, Insuk, S, Banaschewski, T, Neubert, AC, McCarthy, S, Buitelaar, JK, Coghill, D, Dittmann, RW, Konrad, K, Panei, P, et al.
An inventory of European data sources for the long-term safety evaluation of methylphenidate.
European Child & Adolescent Psychiatry
22(10)
:
605 -618
2013
view publication
-
Cardo, E, Coghill, D, Nagy, P, Adeyi, B, Anderson, C, Caballero, B, Higgins, N, Hodgkins, P, Civil, R, Dittmann, RW.
P.7.d.008 Efficacy of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with ADHD: head-to-head responder analyses.
European Neuropsychopharmacology
23:
s603 -s604
2013
view publication
-
Banaschewski, T, Soutullo, C, Lecendreux, M, Johnson, M, Zuddas, A, Hodgkins, P, Adeyi, B, A. Squires, L, Coghill, D.
Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder.
CNS Drugs
27(10)
:
829 -840
2013
view publication
-
Coghill, D, Banaschewski, T, Lecendreux, M, Soutullo, C, Zuddas, A, Sorooshian, S, Adeyi, B, Squires, L, Civil, R.
P.7.d.002 Impact of previous ADHD medication on the efficacy of lisdexamfetamine dimesylate in the treatment of ADHD: post hoc analyses.
European Neuropsychopharmacology
23:
s599 -s600
2013
view publication
-
Coghill, D, Banaschewski, T, Zuddas, A, Johnson, M, Hodgkins, P, Adeyi, B, Squires, L, Civil, R.
P.7.d.001 Health-related quality of life outcomes in a long-term study of lisdexamfetamine dimesylate in children and adolescents with ADHD.
European Neuropsychopharmacology
23:
s598 -s599
2013
view publication